Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

New technologies show potential for better understanding and treating skin conditions with abnormal mucin, but more research is needed for clinical use.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New cancer drugs often cause skin and nail problems.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

CD34 is crucial for skin tumor development in mice.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Bee venom can improve various skin conditions, including varicose veins and psoriasis, and has anti-aging benefits.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Green tea may help with various skin conditions and protect the skin when taken orally or applied topically, but its effectiveness is not always proven.